|
Published by: Datamonitor
Published: Aug. 23, 2001 - 85 Pages
Table of Contents
DATAMONITOR HEALTHCARE
CONTACT DETAILS
Global Director of CNS
EXECUTIVE SUMMARY
Scope
Datamonitor insight into the eating disorders market
Key metrics
TABLE OF CONTENTS
EPIDEMIOLOGY
Anorexia nervosa overview
Definition
Comorbidities
Patient potential
Bulimia nervosa overview
Definition
Comorbidities
Patient potential
Epidemiological conclusion
CLINICAL PRACTICE
Introduction
Diagnosis
Guidelines in existence
Physician diagnosis rate
Treatment
Breakdown of eating disorders within anxiety spectrum
First line treatment for anorexia
First line treatment for bulimia
First line treatment for eating disorders conclusion
Overall treatment of eating disorders
Influence on eating disorders marketing
The lack of therapeutic agents used to treat anorexia
The position of fluoxetine in treating bulimia
The use of antipsychotics
CURRENT EATING DISORDERS MARKET
Anorexia nervosa
Introduction
Prozac
Effexor
Cipramil/Celexa
Other treatment options for anorexia nervosa
Bulimia nervosa
Introduction
Prozac - the lead compound
Luvox
Edronax/Vestra
Wellbutrin
Other treatment options for bulimia nervosa
Eating disorders current market conclusion
The global eating disorders market 2001
Anorexia nervosa
Bulimia nervosa
THE FUTURE DECODED
Unmet needs in treating eating disorders
The eating disorders R&D pipeline
Sertraline
Ticalopride
SR 146131
The eating disorders market 2001-2008
Factors influencing the future eating disorders market
Future drug launches
Eating disorders market forecasts to 2008
Anorexia nervosa
Bulimia nervosa
APPENDIX
Datamonitor's Central Nervous System Business Unit
Table of tables
Epidemiology
Clinical trials
Websites
R&D research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification and quality control
Physician research questionnaire
Diagnosis
Treatment
Unmet needs
Pricing data
Introduction
Source prices
Ex-manufacturer, wholesaler and retail prices
Data validation and margin calculation
Quality control
Patent expiries
AbstractDatamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder. Anxiety Disorders covered: Eating Disorders (Anorexia Nervosa and Bulimia Nervosa) Generalized Anxiety DisorderObsessive Compulsive Disorder Panic DisorderPhobias (Specific Phobia and Agoraphobia)Post Traumatic Stress DisorderPremenstrual Dysphoric Disorder Social Anxiety Disorder
Get Full Details About This Report >>
|
